Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Takeda, Amgen to suspend trials of cancer drug
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08
Japan's Takeda Pharmaceutical Co and U.S. biotech firm Amgen Inc said they would suspend enrolment in the last-stage trials of a key cancer drug candidate following negative study results.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Article Search
Sponsor